Article
Tubulin targets in the pathobiology and therapy of glioblastoma multiforme. I. class III β‐tubulin
31 Jul 2009
Abstract excerpt
Glioblastoma multiforme (GBM) is the most common and deadliest form of primary brain cancer in adults. Despite advances in molecular biology and genetics of gliomas currently there is no effective treatment or promising molecularly targeted experimental therapeutic strategies for these tumors. In previous studies we have shown aberrant overexpression of the class III beta-tubulin isotype (betaIII-tubulin) in GBM...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
